Shares of Canadian cannabis company Canopy Growth Corp CGC were down more than 8 percent Wednesday morning after certain aspects of the company's fiscal second-quarter earnings report disappointed against some of the most conservative estimates, Business Insider reported.
What Happened
Canopy Growth said it lost 1.52 Canadian dollars per share — the U.S. dollar equivalent of $1.15 — in the fiscal second quarter on revenue of CA$23.327 million. Other notable items from the report include:
- Active registered patients rose 34 percent from a year ago to 84,400.
- Kilograms and the kilogram equivalent sold rose 9 percent to 2,197.
- Kilograms harvested rose 265 percent to 15,127.
- The average selling price per gram rose 24 percent to $9.87.
- Inventory and biological assets rose 76 percent to $171 million.
- The company made "limited test shipments" to recreational channels.
- The company ended the quarter with supply commitments in Canada (excluding Ontario) of 70,000 kg.
- The company started shipping value-added products like Softgels capsules.
Why It's Important
Revenue during the second quarter fell well short of the consensus estimate of CA$59.1 million.
What's Next
Canopy Growth's combination of inventory, new products, increased demand from physical retail stores and growing internal and channel efficiencies position it well to command a "significant and sustainable" market share in Canada, CEO Bruce Linton said in a statement. The company continues to eye the U.S. market and is prepared to expand "when it is federally permissible to do so," he said.
Related Links:
What Jeff Sessions' Resignation Could Mean For Cannabis Stocks
The '420 Investor' Talks Canada's Legalization, Calls Cannabis Stocks A Crowded Trade Right Now
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!